| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus a daunorubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia: A propensity score analysis
|
Minakata, Daisuke
|
|
2016
|
42 |
C |
p. 82-87
6 p.
|
artikel
|
| 2 |
A potential role of the NOD genetic background in mouse peritoneal macrophages for the development of primary effusion lymphoma
|
Goto, Hiroki
|
|
2016
|
42 |
C |
p. 37-42
6 p.
|
artikel
|
| 3 |
Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients
|
Achille, Nicholas J.
|
|
2016
|
42 |
C |
p. 68-74
7 p.
|
artikel
|
| 4 |
Cell differentiation and the multiple drug resistance phenotype in human erythroleukemic cells
|
Carrett-Dias, Michele
|
|
2016
|
42 |
C |
p. 13-20
8 p.
|
artikel
|
| 5 |
Chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia: a way to improve the outcome?
|
Niscola, Pasquale
|
|
2016
|
42 |
C |
p. 80-81
2 p.
|
artikel
|
| 6 |
Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia
|
Suleiman, Yaman
|
|
2016
|
42 |
C |
p. 52-58
7 p.
|
artikel
|
| 7 |
Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study
|
Duan, M.-H.
|
|
2016
|
42 |
C |
p. 43-46
4 p.
|
artikel
|
| 8 |
Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes
|
Svobodova, Karla
|
|
2016
|
42 |
C |
p. 7-12
6 p.
|
artikel
|
| 9 |
Decrease of TET2 expression and increase of 5-hmC levels in myeloid sarcomas
|
Xiao, Desheng
|
|
2016
|
42 |
C |
p. 75-79
5 p.
|
artikel
|
| 10 |
Editorial board and publication information
|
|
|
2016
|
42 |
C |
p. IFC-
1 p.
|
artikel
|
| 11 |
Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma
|
Yang, Yu-Qiong
|
|
2016
|
42 |
C |
p. 88-92
5 p.
|
artikel
|
| 12 |
High total metabolic tumor volume in PET/CT predicts worse prognosis in diffuse large B cell lymphoma patients with bone marrow involvement in rituximab era
|
Song, Moo-Kon
|
|
2016
|
42 |
C |
p. 1-6
6 p.
|
artikel
|
| 13 |
Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: Risk factors and efficacy of antibiotic prophylaxis
|
Bainschab, Antonia
|
|
2016
|
42 |
C |
p. 47-51
5 p.
|
artikel
|
| 14 |
Niemann-Pick disease type C1(NPC1) is involved in resistance against imatinib in the imatinib-resistant Ph+ acute lymphoblastic leukemia cell line SUP-B15/RI
|
Naren, Duolan
|
|
2016
|
42 |
C |
p. 59-67
9 p.
|
artikel
|
| 15 |
Pseudogene transcripts: Participants in tumorigenicity and promising therapeutic targets
|
Zhang, Xin
|
|
2016
|
42 |
C |
p. 105-106
2 p.
|
artikel
|
| 16 |
Targeting B-cell non Hodgkin lymphoma: New and old tricks
|
Solimando, Antonio Giovanni
|
|
2016
|
42 |
C |
p. 93-104
12 p.
|
artikel
|
| 17 |
The expression and function of E3 ligase SIAH2 in acute T lymphoblastic leukemia
|
Chen, Hongxia
|
|
2016
|
42 |
C |
p. 28-36
9 p.
|
artikel
|
| 18 |
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the “Rete Ematologica Lombarda”
|
Molteni, Alfredo
|
|
2016
|
42 |
C |
p. 21-27
7 p.
|
artikel
|
Tijdschrift beschrijving